The global pharmaceutical gelatin market is on track for a stable trajectory, with a projected value of USD 1.76 billion by 2030. This translates to a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2023-2030, according to a recent market analysis. The market size was valued at USD 1.15 billion in 2022.

KEY PLAYERS:

Major key players are Capsugel, Gelita AGv, Catelent Inc., Rousselot, Sterling Gelatin, Norland Products Inc, Weishardt, Tessenderlo Group, Roxlor llc, Nitta Gelatin Inc, and other players.

Get Sample PDF @ https://www.snsinsider.com/sample-request/2242 

Market Definition and Applications:

Pharmaceutical gelatin is a specially purified form of gelatin derived from collagen, a protein found in animals. This press release explores the market encompassing pharmaceutical gelatin used in various applications, including:

KEY MARKET SEGMENTATION:

By Application

• Hard Capsules

• Soft Capsules

• Tablets

• Absorbable Hemostats

By Source

• Porcine

• Bovine Skin

• Bovine Bone

• Marine

• Poultry

By Function

• Stabilizing agents

• Thickening agents

• Gelling agents & Other Functions

By Type

• Type A

• Type B

Capsule Shells: Hard and soft capsules containing medications rely on gelatin for their structure and controlled release properties.

Tablets & Other Dosage Forms: Gelatin acts as a binder and bulking agent, facilitating tablet formation and ensuring consistent drug delivery.

Biologics & Vaccine Development: Gelatin plays a crucial role in cell culture processes and stabilizing certain vaccines.

Market Analysis: Drivers and Trends:

The report identifies key factors propelling the pharmaceutical gelatin market forward:

Rising Demand for Oral Dosage Forms: Capsules and tablets remain the most widely used drug delivery methods, driving the demand for pharmaceutical gelatin.

Focus on Patient Compliance: Gelatin-based capsules offer advantages like controlled release and taste masking, promoting patient adherence to medication regimens.

Growth of the Biologics Market: The expanding biologics market, particularly for complex and sensitive drugs, necessitates the use of high-quality pharmaceutical gelatin.

Regulatory Stringency: Stringent regulations governing pharmaceutical excipients ensure the safety and purity of gelatin used in medications.

Impact of Current Events:

The report acknowledges the potential influence of current events:

Russia-Ukraine Conflict: The conflict may cause temporary disruptions in the supply chain for raw materials or processing facilities. However, long-term, the focus on rebuilding healthcare infrastructure could create renewed demand for pharmaceutical gelatin.

Economic Slowdown: A global economic slowdown could lead to reduced healthcare spending, potentially impacting market growth. However, the essential role of pharmaceutical gelatin in drug delivery suggests a relatively stable demand.

Regional Analysis: Growth Dynamics:

The report analyzes regional trends, highlighting potential growth areas:

North America and Europe are expected to hold significant market shares due to established pharmaceutical industries and a strong focus on quality control.

Asia Pacific is projected to witness the fastest growth due to a rapidly expanding pharmaceutical sector, rising disposable income, and increasing demand for affordable medications.

Key Takeaways:

This press release emphasizes the key takeaways from the market analysis:

The growing usage of oral dosage forms and the expanding biologics market are driving the demand for pharmaceutical gelatin.

Focus on patient compliance and stringent regulations governing excipients contribute to market growth.

Emerging economies in Asia Pacific present significant opportunities for market expansion.

Recent Developments:

The press release can be further strengthened by including recent developments in the pharmaceutical gelatin market, such as:

Development of innovative gelatin formulations with improved functionality and stability.

Growing interest in plant-based alternatives to traditional animal-derived gelatin.

Increasing focus on sustainability and ethical sourcing of raw materials for pharmaceutical gelatin production.

By incorporating these elements, this press release paints a comprehensive picture of the pharmaceutical gelatin market, highlighting its vital role in drug delivery and its potential for steady growth in the coming years.

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development & Strategy

info@snsinsider.com

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

Website: https://www.snsinsider.com